Neurology Research Review – Issue 93
In this issue, evidence suggests that a Mediterranean diet may have a protective role against MS, the AFFINITY study reports negative findings for opicinumab, and an analysis of data from the MSBase registry suggests that switching to an anti-CD20 drug may be the best strategy for people who relapse on natalizumab. Also in this issue, […]
ECTRIMS Patient Community Day 2025 Impact Report
In September 2025, MSNZ’s Co-Vice President, Graham Walker, and his wife Julie travelled to Barcelona, where Graham represented us at ECTRIMS—the world’s largest MS research conference. His mission? To bring back the latest updates on treatments and research for MS. (You can read more about his trip and key learnings here.) Alongside other panel appearances, […]
ECTRIMS, Barcelona 2025
Report by Graham Walker, October 20th. Note from MSNZ: In September 2025 MSNZ Co-Vice President and person with MS Graham Walker and his wife Julie, travelled to Barcelona to attend the 41st European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS). As an active advocate with a strong interest in science, research and […]
Online Multiple Sclerosis PSYchological WELLbeing Programme (MS PSY-WELLP): Randomised Controlled Trial and interviews
Living with MS can be tough – not just physically, but emotionally too. An exciting new study called MS PSY WELL-P, is a peer-led online program designed to explore how a short course can boost psychological well-being for people with MS. The course is free, flexible, and built to support mental health in everyday life. […]
Research Opportunity for Young Adults
Nikki Singh, a PhD candidate in the Faculty of Medical and Health Sciences, is conducting research into the lived experiences of young people with autoimmune diseases. Research summary: Nikki’s research explores how autoimmune diseases impact identity among young adults aged 18 to 30. While often viewed primarily as biological conditions to be managed, autoimmune diseases […]
MS Brain Health Seminar: A Review
On 12th July 2024 Multiple Sclerosis New Zealand (MSNZ) co-hosted our MS Brain Health seminar in Auckland with the NZ MS Research Trust and MS Auckland. Thank you to all attendees that came to hear from our special guest speaker, Professor Helmut Butzkueven. Professor Butzkueven captured the audience’s attention, providing updates on the MS Brain […]
MS Brain Health Webinar: MS in NZ and the Hidden Symptoms – Recording Now Available
We invite you to join us to learn of MSNZ’s latest developments and hear from guest speaker German Neurologist, Dr Matthias Grothe, on the impacts of hidden symptoms of MS, and what we can do to alleviate them. Dr Matthias Grothe is a German neurologist specializing in the treatment of MS-patients. His outpatient clinic covers a […]
Ectrims 2024 Conference Review
ECTRIMS (European Committee for Treatment and Research in MS) is the world’s largest MS research meeting, taking place, this year, in Copenhagen, Denmark. It saw more than 8,500 researchers, healthcare providers, and advocates from 103 countries gather to share progress in advancing cures for multiple sclerosis at the 40th Annual Meeting of ECTRIMS. Dr. John […]
MS Get a Head Start – Online Research Study
MS Get a Head Start are looking for people living with multiple sclerosis to take part in a 6-week online exercise and education programme, as part of a research study with AUT. The good news is that you can complete the programme in the comfort of your own home, on days and times that suit […]
Study: CFS biomarkers at the time of diagnosis may aid in MS prognosis
Certain biomarkers in the cerebrospinal fluid (CSF) — the fluid surrounding the brain and spinal cord — around the time of a multiple sclerosis (MS) diagnosis may help predict the time to reaching certain disability milestones among people with a relapsing-remitting (RRMS) disease course, according to findings from a recent study. Such markers also were associated with short-term relapse […]